Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mowat

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
The British Journal of Dermatology|September 1, 1996
Papular mucinosis: is the inflammatory cell infiltrate neoplastic? The presence of a monotypic plasma cell population demonstrated by in situ hybridizationB J Clark, A Mowat, M E Fallowfield, et al.
Lancet (London, England)|January 6, 1973
Outbreak of serum hepatitis associated with tattooingN A Mowat, P W Brunt, F Albert-Recht, et al.
Genes & Cancer|July 23, 2011
Duplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse PlasmacytomasFrancis Wiener, Ann-Kristin Schmälter, Michael R A Mowat, et al.
Plos One|July 14, 2012
The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancerMohammad Golam Sabbir, Heather Prieditis, Esther Ravinsky, et al.
Digestive Diseases and Sciences|January 1, 1983
Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trialS C Glover, J S Cantlay, J Weir, et al.
Archives of Disease in Childhood|July 1, 1988
Functional residual capacity related to hepatic diseaseA Greenough, J Pool, C Ball, et al.
Clinical and Experimental Dermatology|May 1, 1991
Erythema elevatum diutinum--an unusual association with ulcerative colitisK Buahene, M Hudson, A Mowat, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1990
The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulcerationA A Dunk, U Prabhu, A Tobin, et al.
Gut|June 1, 1976
Plasma oestrogens in men with chronic liver diseaseJ R Green, N A Mowat, R A Fisher, et al.
BMC Cancer|September 11, 2015
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarityPratima Basak, Rachelle Dillon, Heather Leslie, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|September 1, 1996
Papular mucinosis: is the inflammatory cell infiltrate neoplastic? The presence of a monotypic plasma cell population demonstrated by in situ hybridizationB J Clark, A Mowat, M E Fallowfield, et al.
Lancet (London, England)|January 6, 1973
Outbreak of serum hepatitis associated with tattooingN A Mowat, P W Brunt, F Albert-Recht, et al.
Genes & Cancer|July 23, 2011
Duplication of Subcytoband 11E2 of Chromosome 11 Is Regularly Associated with Accelerated Tumor Development in v-abl/myc-Induced Mouse PlasmacytomasFrancis Wiener, Ann-Kristin Schmälter, Michael R A Mowat, et al.
Plos One|July 14, 2012
The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancerMohammad Golam Sabbir, Heather Prieditis, Esther Ravinsky, et al.
Digestive Diseases and Sciences|January 1, 1983
Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trialS C Glover, J S Cantlay, J Weir, et al.
Archives of Disease in Childhood|July 1, 1988
Functional residual capacity related to hepatic diseaseA Greenough, J Pool, C Ball, et al.
Clinical and Experimental Dermatology|May 1, 1991
Erythema elevatum diutinum--an unusual association with ulcerative colitisK Buahene, M Hudson, A Mowat, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1990
The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulcerationA A Dunk, U Prabhu, A Tobin, et al.
Gut|June 1, 1976
Plasma oestrogens in men with chronic liver diseaseJ R Green, N A Mowat, R A Fisher, et al.
BMC Cancer|September 11, 2015
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarityPratima Basak, Rachelle Dillon, Heather Leslie, et al.
Pageof 11